Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis

PURPOSE: To assess the evidence for decision making, at the health care and the patient levels, regarding the use of gene expression assays to inform chemotherapy decisions in breast cancer patients with intermediate clinical risk of recurrence. METHODS: Systematic literature searches were performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallerstedt, Susanna M., Nilsson Ek, Astrid, Olofsson Bagge, Roger, Kovács, Anikó, Strandell, Annika, Linderholm, Barbro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419442/
https://www.ncbi.nlm.nih.gov/pubmed/32504183
http://dx.doi.org/10.1007/s00228-020-02914-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419442/
https://www.ncbi.nlm.nih.gov/pubmed/32504183
http://dx.doi.org/10.1007/s00228-020-02914-z

Ejemplares similares